Welcome to BCIQ: BioCentury Online Intelligence.
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange.

Please explore the profile and if you wish to find out more about BCIQ - please Click Here

Axis-Shield plc

Print preview

(LSE:ASD; OSE:ASD)

General Information

Location	Dundee, U.K.
Region
Country	U.K.
Business Category	Diagnostic
Year Founded	1999
Website	www.axis-shield.com
Development Status	Market (diagnostic) (03/18/2004)

Archive Items are loading

Financial Information

Financing Summary

Total Money Raised	Number of Completed Financings	Last Financing Date	Last Financing Type	Number of All Financings
$28,393,000	2	04/24/2002	Placing (other)	2

Financing Details

Company Name	Financing Status	Date Completed	Financing Type	Amount Raised	Share Price	Post-Money Valuation
Axis-Shield plc	Completed	04/24/2002	Placing (other)	$11,993,000	360p	$253,060,117
Axis-Shield plc	Completed	07/05/1999	Rights offering (other)	$16,400,000	354-420p

Financial Performance Summary

	2H07	1H08	2H08
As Of Date	12/31/2007	06/30/2008	12/31/2008
Profit and loss
Sales	$0	$0	$0
Revenues	$66,668,511	$84,948,855	$1,218,463,615
SG&A	$24,920,824	$31,125,022	$24,381,246
R&D	$7,310,161	$8,243,075	$13,794,348
Operating Income	$1,682,686	$3,714,460	($5,321,648)
Net Income	$2,389,097	$2,605,695	$4,592,814
EPS		$0.05
Diluted EPS		$0.05
Shares Outstanding	48,730,000	49,070,000	49,170,000
Balance Sheet
Cash	$24,277,911	$10,016,699	$13,586,110
Valuations
Market Cap	$236,033,501	$297,280,781	$218,698,326
Tech Value	$211,755,591	$287,264,082	$205,112,217
R&D/Sales
R&D/Revenue	0.11	0.10	0.01
SG&A/Sales
SG&A/Revenue	0.37	0.37	0.02
Currency Rate
Rate	1.9843	1.9906	1.4461

Stocks Annual Chart

Pipeline Information

Pipeline Summary

Disease Category	Research	Phase I	Phase I/II	Phase II	Phase II/III	Phase III	Registration	Approved	Marketed
Diagnostic	-	-	-	-	-	-	-	4	4
Endocrine	-	-	-	-	-	-	-	-	1
Total	-	-	-	-	-	-	-	4	5

Pipeline Details - Originated and out-licensed products (9 records)

Product Names	Disease Category	Standard Indication	Partners	Milestones	Latest Stage of Development
Afinion ACR Test (Informal)	Endocrine	Diabetes			Marketed
Afinion HbA1c test (Informal)	Diagnostic	Endocrine, Diagnostic	Abbott Laboratories		Marketed

Pipeline Details - In-licensed products

ACCESS TO BIOCENTURY ONLINE INTELLIGENCE (BCIQ) AND THE BIOCENTURY ARCHIVES IS LIMITED ONLY TO AUTHORIZED SUBSCRIBERS WHO HAVE READ AND AGREED TO THE BIOCENTURY USER AGREEMENT, WHICH SOLELY GOVERNS THE CONDITIONS FOR USE OF ANY OF THESE SERVICES AND THE INFORMATION CONTAINED THEREIN. All contents Copyright © 1994-2009 BioCentury Publications, Inc. ALL RIGHTS RESERVED. These Services and the Content contained therein are protected under U.S. and foreign copyright and intellectual property laws, and may not be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions at www.biocentury.com. BioCentury®; The Bernstein Report on BioBusiness®; Because Real Intelligence is Hard to Find™; BCIQ™; The BioCentury 100™; and The Clear Route to ROI™ are trademarks of BioCentury Publications, Inc., P.O. Box 1246 San Carlos, CA 94070.